In November 2017, the health watchdog NICE issued a recommendation for a vaginal mesh ban. The month before, the government opposed calls to ban the treatment.
These two opposing viewpoints provide just one example of the controversy that still surrounds vaginal mesh implants, which have faced criticism both in the UK and across the world.
The mesh implants, which are used to treat issues such as pelvic organ prolapse (POP) and stress urinary incontinence (SUI), have widely been condemned by women who have undergone the treatment, many of whom now have irreversible complications and constant pain.
This month, a Bard mesh recall has been initiated, and the company has decided to no longer produce and distribute their mesh devices.
The mesh products made by Bard – C.R. Bard (Becton, Dickinson and Company (BD)) – are for treating POP (pelvic organ prolapse) and SUI (stress urinary incontinence). The recall is voluntary, and the advice so far is that the devices don’t need to be removed. However, anyone who suffers with complications should seek advice immediately.
The recall has been launched with immediate effect, according to the company’s written publications.